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Abstract The evolution of influenza viruses is fundamentally shaped by within-host processes.
However, the within-host evolutionary dynamics of influenza viruses remain incompletely
understood, in part because most studies have focused on infections in healthy adults based on
single timepoint data. Here, we analyzed the within-host evolution of 82 longitudinally sampled
individuals, mostly young children, infected with A/H1N1pdm09 or A/H3N2 viruses between 2007
and 2009. For A/H1N1pdm09 infections during the 2009 pandemic, nonsynonymous minority
variants were more prevalent than synonymous ones. For A/H3N2 viruses in young children, early
infection was dominated by purifying selection. As these infections progressed, nonsynonymous
variants typically increased in frequency even when within-host virus titers decreased. Unlike the
short-lived infections of adults where de novo within-host variants are rare, longer infections in
young children allow for the maintenance of virus diversity via mutation-selection balance creating
potentially important opportunities for within-host virus evolution.
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Introduction
Influenza A viruses (IAV) are some of the most prevalent human respiratory pathogens, infecting hun-
dreds of millions of people worldwide each year. Because of the high error rates of the viral RNA
polymerase complex, de novo mutants are generated as the viruses replicate within infected hosts
(Andino and Domingo, 2015). However, the emergence of these variants within host does not
mean that they will become the majority variant within the infected host or be transmitted between
hosts. The evolution of IAVs is the product of a complex mosaic of evolutionary processes that
include genetic drift, positive selection (Smith et al., 2004), transmission bottleneck effects
(Varble et al., 2014; McCrone et al., 2018), and global migration patterns (Russell et al., 2008;
Rambaut et al., 2008). Importantly, the resulting evolutionary dynamics can differ at the individual
and population levels (Nelson and Holmes, 2007).
For seasonal IAVs at the global population level, antibody-mediated immune selection pressure
from natural infection or vaccination positively selects for novel antigenic variants that facilitate
immune escape, resulting in antigenic drift (Smith et al., 2004). However, at the within-host level,
the role of positive selection exerted by immunity is less obvious. Several next-generation sequenc-
ing studies of typical, short-lived seasonal IAV infections in adult humans showed that intra-host
genetic diversity of influenza viruses is low and dominated by purifying selection (McCrone et al.,
2018; Dinis et al., 2016; Debbink et al., 2017; Valesano et al., 2020; Sobel Leonard et al., 2016).
Additionally, large-scale comparative analyses of IAV hemagglutinin (HA) consensus sequences
found limited evidence of positive selection on HA at the individual level regardless of the person’s
expected influenza virus infection history (Han et al., 2019). Importantly, these studies focused on
virus samples from only one or two timepoints, mostly early in infection, limiting the opportunities to
study how virus populations evolved over the course of infection.
Separate from seasonal IAVs, zoonotic IAVs constantly pose new pandemic threats. Prior to
becoming human-adapted seasonal strains, IAVs are introduced into the human population from an
animal reservoir through the acquisition of host-adaptive mutations, sometimes via reassortment,
resulting in global pandemics such as the 2009 swine influenza pandemic (Smith et al., 2009). In the
2009 pandemic, global virus genetic diversity increased rapidly during the early phases of the pan-
demic as a result of rapid transmissions in the predominantly naı̈ve human population (Su et al.,
2015). Over subsequent waves of the pandemic, host-adapting mutations that incrementally
improved viral fitness and transmissibility in humans of A/H1N1pdm09 viruses emerged
(Elderfield et al., 2014), eventually reaching fixation in the global virus population (Nogales et al.,
2018).
At the individual level, the within-host evolutionary dynamics of the pandemic A/H1N1pdm09
virus, particularly in the early stages of the 2009 pandemic, have been relatively underexplored. To
date, the only within-host genetic diversity analysis of A/H1N1pdm09 viruses during the initial phase
of the pandemic was based on mostly single-timepoint samples collected within ~7 days post-symp-
tom onset (Poon et al., 2016). Despite initial findings of high within-host diversity and loose trans-
mission bottlenecks (Poon et al., 2016), these results were later disputed due to technical anomalies
and subsequent reanalyses of a smaller subset of the original data found that intra-host genetic
diversity of the pandemic virus was low and comparable to levels observed in seasonal IAVs
(Xue and Bloom, 2019; Poon et al., 2019). It remains unclear how frequently host-adaptive muta-
tions appear within hosts infected by a pandemic IAV and if these mutants are readily transmitted
between individuals.
Here, we deep-sequenced 275 longitudinal clinical specimens sampled from 82 individuals resid-
ing in Southeast Asia between 2007 and 2009 that were either infected with seasonal A/H3N2 or
pandemic A/H1N1pdm09 viruses. By analyzing minority variants found across the whole IAV
genome, we characterized the evolutionary dynamics of within-host virus populations in these sam-
ples collected up to 2 weeks post-symptom onset.
Results
Study participants
The A/H3N2 virus samples were collected from 51 unlinked individuals as part of an oseltamivir dos-
age trial (South East Asia Infectious Disease Clinical Research Network, 2013; Koel et al., 2020).
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48 of the 51 A/H3N2 virus-infected individuals were young children (median age = 2 years; inter-
quartile range [IQR] = 2–3 years) at the time of sampling and most had low or no detectable anti-
influenza virus antibody titers on days 0 and 10 post-symptom onset (Koel et al., 2020). Given that
young children are substantial contributors to influenza virus transmission (Worby et al., 2015;
Viboud et al., 2004), the samples analyzed here offer a valuable opportunity to investigate the
within-host IAV evolutionary dynamics in this key population. The A/H1N1pdm09 virus specimens
were collected from 32 individuals up to 12 days post-symptom onset. These individuals include
both children and adults (median age = 10 years; IQR = 4–20 years) infected during the first wave of
the pandemic in Vietnam (July–December 2009). 15 of the 32 individuals (including six index
patients) were sampled in a household-based influenza cohort study (Horby et al., 2012). The
remaining 16 unlinked individuals were hospitalized patients that were involved in two different osel-
tamivir treatment studies (South East Asia Infectious Disease Clinical Research Network, 2013;
Hien et al., 2010) Details of all study participants are described in the respective cited studies and
Supplementary file 4.
Genetic diversity of within-host virus populations
We used the number of minority intra-host single-nucleotide variants (iSNVs;  2% in frequencies) to
measure the levels of genetic diversity of within-host IAV populations. Similar to previous studies
(McCrone et al., 2018; Dinis et al., 2016; Debbink et al., 2017; Sobel Leonard et al., 2016),
within-host genetic diversity of human A/H3N2 virus populations was low (median = 11 iSNVs, IQR =
7–16; Figure 1A). Within-host genetic diversity of pandemic A/H1N1pdm09 virus populations was
also low, with a median number of 21 iSNVs (IQR = 13.5–30.0; Figure 1B) identified. Cycle threshold
(Ct) values, and thus likely virus shedding, correlated with the number of days post-symptom onset
for both IAV subtypes (A/H3N2: Spearman’s  ¼ 0:468, p ¼ 1:38 10 10; A/H1N1pdm09:  ¼ 0:341,
p ¼ 0:048; Figure 1C, D). The number of iSNVs observed in within-host A/H3N2 virus populations
weakly correlated with days since onset of symptoms in patients ( ¼ 0:463,p ¼ 2:22 10 10) and Ct
values ( ¼ 0:508,p ¼ 1:20 10 12), suggesting that as infection progresses genetic variants accumu-
late within-host even as virus population size decreases (Figure 1A). On the other hand, there was
no significant correlation between the number of iSNVs observed in within-host A/H1N1pdm09 virus
populations and Ct values ( ¼ 0:198,p ¼ 0:21) or days post-symptom onset
( ¼  0:021,p ¼ 0:91; Figure 1B).
Within-host evolutionary rates of IAV
To investigate within-host evolutionary dynamics, empirical rates of synonymous, nonsynonymous,
and premature stop codon (i.e., nonsense) iSNVs were calculated by normalizing the summation of
observed iSNV frequencies with the number of available sites and time since symptom onset (see
Materials and methods). The overall within-host evolutionary rates of A/H3N2 viruses observed here
are in the same order of magnitude (< ~ 10 5 divergence per site per day) as those reported in previ-
ous within-host seasonal influenza virus evolution studies (Figure 2A; Xue and Bloom, 2020). Synon-
ymous evolutionary rates were significantly higher than nonsynonymous rates during the initial phase
of A/H3N2 virus infections (Figure 2A), primarily in the polymerase complex and HA genes
(Figure 2A, Figure 2—figure supplement 1, and Figure 3—figure supplement 1). Importantly,
nonsynonymous variants gradually accumulated, increasing in rates around 4 days post-symptom
onset to similar levels relative to synonymous rates. To ensure that this temporal trend was not due
to aggregated effects across multiple individuals, we performed linear regression on the computed
evolutionary rates for each A/H3N2-infected individual with at least three sampling timepoints
(n = 39). Nonsynonymous evolutionary rates were positively correlated against time for 25/39 indi-
viduals (64%; Figure 2—figure supplement 3). In contrast, synonymous evolutionary rates were neg-
atively correlated against time for 27 (69%) individuals.
Consolidating over all samples, most nonsynonymous variants were found in the nucleoprotein
(NP) and neuraminidase (NA) gene segments (nonsynonymous to synonymous variant [NS/S] ratios =
1.69 [NP] and 1.32 [NA], whereas NS/S ratios were 1 for all other gene segments; Figure 2—figure
supplement 1 and Supplementary file 1). While nonsynonymous NA mutations associated with
oseltamivir resistance were positively selected for a subset of individuals in response to the antiviral
Han, Felix Garza, Welkers, et al. eLife 2021;10:e68917. DOI: https://doi.org/10.7554/eLife.68917 3 of 29
Research article Evolutionary Biology Microbiology and Infectious Disease
treatment (Koel et al., 2020), nonsynonymous changes to NP were likely mediated by protein stabil-
ity, T-cell immune response, and/or host cellular factors (see next section).
For A/H1N1pdm09 viruses during the first wave of the pandemic, the overall within-host evolu-
tionary rate was as high as ~10 4 divergence per site per day in some samples on day 0 post-symp-
tom onset (Figure 2B). We observed higher nonsynonymous evolutionary rates relative to
synonymous ones initially after symptom onset but were unable to determine if they were
A B
C D
Figure 1. Genetic diversity of within-host influenza A virus populations. Box plots summarizing the number of intra-host single-nucleotide variants
(iSNVs; median, interquartile range [IQR], and whiskers extending within median ±1.5  IQR) identified in samples with adequate breadth of coverage
across the whole influenza virus genome in (A) seasonal A/H3N2 and (B) pandemic A/H1N1pdm09 virus samples, stratified by day(s) since symptom
onset or qPCR cycle threshold (Ct) values. (C, D) Ct values as a function of day(s) since symptom onset for A/H3N2 viruses (C) and A/H1N1pdm09
viruses (D).
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Sequence coverage across all influenza gene segments and samples.
Figure supplement 2. Frequencies of nucleotide variants found in A/H3N2 viral reads sequenced from overlapping amplicons.
Figure supplement 3. Maximum-likelihood phylogeny of putative majority (consensus) and minority whole-genome sequences (by concatenating all
eight gene segments) of A/H3N2 virus samples.
Figure supplement 4. Maximum-likelihood phylogeny of putative majority (consensus) and minority whole-genome sequences (by concatenating all
eight gene segments) of H1N1pdm09 virus samples.
Figure supplement 5. Pearson’s correlation between the first day of oseltamivir treatment administered to patients and the last day on which viral
samples with cycle threshold (CT) values 35 were collected.
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significantly different due to the low number of samples (i.e., median = 2 samples per day post-
symptom onset). In turn, we also could not meaningfully characterize the temporal trends of within-
host evolution for the pandemic virus with this dataset. Nonetheless, consolidating over all samples
across all timepoints, there were significantly higher rates of accumulation of nonsynonymous var-
iants in the polymerase basic 2 (PB2), polymerase acidic (PA), HA, and matrix (M) gene segments
(Figure 2B, Figure 2—figure supplement 2, and Figure 3—figure supplement 2). All gene seg-
ments also yielded NS/S ratios > 1 (Supplementary file 1).
A B
Figure 2. Box plots (median, interquartile range [IQR], and whiskers extending within median ±1.5  IQR) summarizing the empirical within-host
evolutionary rates of (A) seasonal A/H3N2 viruses and (B) pandemic A/H1N1pdm09 viruses. Top panel shows the evolutionary rate of individual gene
segments over all timepoints (rg) while the bottom panel depicts the genome-wide evolutionary rate (rt ) for each day since symptom onset. All rates are
stratified by substitution type (synonymous – blue; nonsynonymous – red; gray – stop codon). Wilcoxon signed-rank tests were performed to assess if
the paired synonymous and nonsynonymous evolutionary rates are significantly distinct per individual gene segment or timepoint (annotated with * if
p<0:05). This was done for all sets of nonsynonymous and synonymous rate pairs except for those computed per day since symptom onset for A/
H1N1pdm09 viruses due to the low number of data points available (median number of A/H1N1pdm09 virus samples collected per day since symptom
onset = 2). Note that the scales of the y axes differ between (A) and (B) to better show rate trends.
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Box plots (median, interquartile range [IQR], and whiskers extending within median ±1.5  IQR) summarizing the empirical
within-host evolutionary rates (rg;t ) of different H3N2 viral gene segments.
Figure supplement 2. Box plots (median, interquartile range [IQR], and whiskers extending within median ±1.5  IQR) summarizing the empirical
within-host evolutionary rates (rg;t ) of different H1N1pdm09 viral gene segments.
Figure supplement 3. Linear regression of within-host synonymous and nonsynonymous evolutionary rates of within-host A/H3N2 virus samples.
Figure supplement 4. Box plots (median, interquartile range [IQR], and whiskers extending within median ±1.5  IQR) summarizing the empirical daily
within-host evolutionary rates of seasonal A/H3N2 viruses.
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Intra-host minority variants
Most of the iSNVs identified for both virus subtypes were observed at low frequencies (2–5%; Fig-
ure 3) and appear to be stochastically introduced across the virus genome (Figure 4). Purifying
selection dominated within-host seasonal A/H3N2 virus populations as the ratio of nonsynonymous
to synonymous variants was 0.72 across all samples and variant frequencies (Figure 3A and Fig-
ure 3—figure supplement 1). Of note, the canonical antigenic sites of the HA gene segment
(Wiley et al., 1981) of the A/H3N2 virus populations experienced strong negative selection as evi-
denced by the occurrence of synonymous variants (median frequency = 0.14, IQR range = 0.09–
0.27) at far greater frequencies relative to those at non-antigenic sites of HA (median frequency =
0.03, IQR range = 0.03–0.05; Mann–Whitney U test p ¼ 1:18 10 24; Figure 4C). There were no sig-
nificant differences in the frequencies of nonsynonymous iSNVs between the antigenic sites of H3
(median frequency = 0.04, IQR range = 0.03–0.06) and the rest of the HA gene segment (median fre-
quency = 0.03, IQR range = 0.02–0.06; Mann–Whitney U test p ¼ 0:29; Figure 4C). In contrast, there
were 1.94 times as many nonsynonymous minority iSNVs relative to synonymous ones identified in
the pandemic A/H1N1pdm09 virus samples (Figure 3B and Figure 3—figure supplement 2). Vari-
ant frequencies of nonsynonymous iSNVs found in the antigenic epitopes of H1 (Caton et al., 1982)
(median frequency = 0.04, IQR range = 0.04–0.05) were, however, not significantly different from
those of non-antigenic sites (median frequency = 0.05, IQR range = 0.03–0.16; Mann–Whitney U test
p ¼ 0:34; Figure 4D).
As observed in a previous study using different data (Xue and Bloom, 2020), premature
stop codon (nonsense) mutations accumulated within-host, though only at low rates. Here, we
observed similarly low median nonsense rates, ranging between 0 and 1.29  10 6 divergence per
site per day across the entire A/H3N2 virus genome over the course of infection (IQR limits range
between 0 and at most, 1.82  10 6 divergence per site per day; Figure 2A). Premature
stop codons accumulated in the matrix (M) genes predominantly but also appeared in all other influ-
enza gene segments within various individuals (Figures 2A and 4A). Nonsense mutations also accu-
mulated within the A/H1N1pdm09 virus samples (Figure 2B). Similar to A/H3N2 viruses, nonsense
A B
Figure 3. Histogram of the mean number of minority intra-host single-nucleotide variants (iSNVs) identified per sample across all. (A) A/H3N2 and (B)
A/H1N1pdm09 virus specimens, sorted by frequency bins of 5% and substitution type (synonymous – blue; nonsynonymous – red; stop-codon – gray).
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Histogram of the mean number of minority intra-host single-nucleotide variants (iSNVs) identified per sample across all H3N2
viral gene segments across all samples sorted by frequency bins of 5% and substitution type (synonymous – blue; nonsynonymous – red; gray – stop
codon).
Figure supplement 2. Histogram of the mean number of minority intra-host single-nucleotide variants (iSNVs) identified across all H1N1pdm09 viral
gene segments across all samples sorted by frequency bins of 5% and substitution type (synonymous – blue; nonsynonymous – red; stop-codon – gray).
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Figure 4. Intra-host single-nucleotide variants in within-host IAV populations. (A) Breakdown of intra-host single-nucleotide variants (iSNVs) identified in
seasonal A/H3N2 virus samples. The top panels plot the nucleotide positions where iSNVs were found in at least two subjects. The bottom panels show
the frequencies at which iSNVs were identified. For sites with iSNVs that were found in two or more subjects, the interquartile ranges of variant
frequencies are plotted as vertical lines and the median frequencies are marked with a dash. If the iSNV was only found in one subject, its
corresponding frequency is plotted as a circle. All iSNVs are stratified to either synonymous (blue), nonsynonymous (red), or stop codon (gray) variants.
Only the nonsynonymous variants are plotted if both types of variants are found in a site. Positions of antigenic sites of the hemagglutinin (HA)_ gene
segment (Igarashi et al., 2010) are marked in green on the top panels. (B) Box plots of the frequencies of synonymous and nonsynonymous variants
between antigenic and non-antigenic sites of seasonal A/H3N2 HA gene segment. (C) Similar plots to (A) for iSNVs found in pandemic A/H1N1pdm09
virus samples. (D) Similar plots to (B) for HA iSNVs identified in the pandemic A/H1N1pdm09 virus samples.
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. Plots of intra-host hemagglutinin (HA) amino acid variants in A/H3N2-infected individuals.
Figure supplement 2. Plots of intra-host neuraminidase (NA) amino acid variants in A/H3N2-infected individuals.
Figure supplement 3. Plots of intra-host nucleoprotein (NP) amino acid variants in A/H3N2-infected individuals.
Figure supplement 4. Plots of M2 protein intra-host amino acid variants in A/H3N2-infected individuals.
Figure supplement 5. Plots of hemagglutinin (HA) intra-host amino acid variants in A/H1N1pdm09-infected individuals.
Figure supplement 6. Plots of neuraminidase (NA) intra-host amino acid variants in A/H1N1pdm09-infected individuals.
Figure supplement 7. Plots of M2 protein intra-host amino acid variants in A/H1N1pdm09-infected individuals.
Figure supplement 8. Frequency distributions of intra-host single-nucleotide variants (iSNVs) below the 2% variant calling threshold found in
nucleotide positions NP-1150 and M-917 that encode for amino acid sites NP-384 and M2-77, respectively.
Figure supplement 9. Plots of within-host recurring A/H3N2 amino acid variants NP-G384R and M2-R77* based on variant calls and frequencies after
remapping sample reads to their respective sample consensus sequence.
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mutation rates were much lower compared to the synonymous and nonsynonymous counterparts
(median genome-wide rate across all samples between 0 and 1.43  10 6 divergence per site per
day; IQR limits between 0 and 2.18  10 6 divergence per site per day).
The premature stop codon mutations were mostly found at low frequencies for both influenza
subtypes (<10%; Figure 3). The exception lies with one of the A/H3N2 virus samples where a prema-
ture stop codon was found in position 77 of the M2 ion channel with variant frequency as high as
34.6% (patient 1843, day 6 since symptom onset; Figure 4A and Figure 4—figure supplement 4).
The premature stop codon in M2-77 was also found in 27 other individuals across multiple time-
points, albeit at a much lower frequency that never amounted more than 10% (Figure 4A and Fig-
ure 4—figure supplement 4). This was unlikely to be a sequencing artifact resulting from a mistaken
incorporation of the primer sequence as its carboxyl terminal falls outside the coding region of the
M gene segment (Supplementary file 3) and the variant frequencies would have been much higher
in all samples if this was the case.
Despite the dominance of purifying selection in seasonal A/H3N2 intra-host viral populations, we
detected several nonsynonymous variants of interest. Amino acid variants emerging in the HA and
NA proteins were discussed in a previous work (Koel et al., 2020; Appendix A1). In the NP, there
were two notable nonsynonymous variants, D101N/G and G384R, that appeared in multiple individ-
uals who were sampled independently between 2007 and 2009 (Figure 4A and Figure 4—figure
supplement 3). D101N/G was found in seven different patients and at least for D101G the mutation
was previously linked to facilitating escape from MxA, a key human antiviral protein (Mänz et al.,
2013). However, the nonsynonymous mutation was only found in low frequencies and remained
invariant during the respective courses of infection for all seven patients (median variant frequency
across all samples = 0.03; IQR = 0.02–0.07).
NP-G384R emerged in 16 unlinked patients infected by A/H3N2 virus. Even though G384R did
not become the majority variant in any of these individuals (median variant frequency across all sam-
ples = 0.14; IQR = 0.07–0.20), the variant emerged around days 4–5 post-symptom onset and mostly
persisted within each individual for the rest of sampled timepoints. G384R is a stabilizing mutation in
the A/Brisbane/10/2007 A/H3N2 virus NP background (Ashenberg et al., 2013) that is similar to the
viruses investigated here. Interestingly, position 384 is an anchor residue for several NP-specific epit-
opes recognized by specific cytotoxic T lymphocytes (CTLs) that are under continual selective pres-
sure for CTL escape (Berkhoff et al., 2005; Gog et al., 2003). The wild-type glycine residue is
known to be highly deleterious even though it was shown to confer CTL escape among HLA-
B*2705-positive individuals (Gong et al., 2013; Rimmelzwaan et al., 2004; Berkhoff et al., 2004).
Using a maximum-likelihood (ML) approach to reconstruct and estimate the frequencies of the
most parsimonious haplotypes of each gene segment, we computed linkage disequilibrium and
found evidence of potential epistatic co-variants to NP-G384R in the A/H3N2 virus populations of
multiple individuals (Figure 5 and Supplementary file 2). When analyzing how these variants could
alter protein stability using FoldX, the stabilizing effects of G384R (mean DDG ¼  3:84 kcal/mol [SD
= 0.06 kcal/mol]) were found to alleviate the likely destabilizing phenotype of a functionally relevant
linked variant in two of the three co-mutation pairs identified in separate individuals (i.e., G384R/
M426I and G384R/G102R; Supplementary file 2). In the first individual (subject 1224), M426I was
inferred to have emerged among the viral haplotypes encoding NP-G384R on the 10th day post-
symptom onset (D10). M426I may be compensating for T-cell escape that was previously conferred
by 384G even though the two amino acid sites are anchor residues of different NP-specific CTL epit-
opes (Berkhoff et al., 2005). M426I was found to be highly destabilizing (mean DDG ¼ 2:61 kcal/mol
[standard deviation, SD = 0.05 kcal/mol]; Table 1) but when co-mutated with G384R, stability
changes to NP were predicted to be neutral (mean DDG ¼  0:42 kcal/mol [SD = 0.06 kcal/mol]). In
the second individual (subject 1686), G102R was likely linked to G384R in the within-host virus popu-
lations found in the D10 sample. As a single mutant, G102R is also destabilizing to NP (mean
DDG ¼ 4:87 kcal/mol [SD = 0.00 kcal/mol]). However, when combined with G384R, NP stability was
only weakly destabilizing (mean DDG ¼ 0:76 kcal/mol [SD = 0.09 kcal/mol]). G102R was previously
found to bypass the need for cellular factor importin-a7, which is crucial for viral replication and
pathogenicity of IAVs in humans (Resa-Infante et al., 2015; Resa-Infante et al., 2019;
Gabriel et al., 2011).
For the pandemic A/H1N1pdm09 viruses, most of the nonsynonymous variants were found singu-
larly in individual patients (Figure 4B). Putative HA antigenic minority variants were found in four
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individuals in distinct amino acid sites (G143E, N159K, N197K, and G225D; H3 numbering without
signal peptide; Figure 4—figure supplement 5). All of these variants were found at frequencies
 5% and the wild-type residues have been conserved in the corresponding positions globally to
date, with the exception of position 225. Here, HA-225G was the majority variant (76%) in a hospital-
ized individual (subject 11-1022; Supplementary file 4) and D225G is linked to infections with severe
disease outcomes (Mak et al., 2010). Furthermore, one of the few nonsynonymous iSNVs that co-
emerged in multiple unlinked patients was found in the usually conserved stem of the HA protein,
L455F/I (H3 numbering without signal peptide), appearing in 17 separate individuals (Figure 4B and
Figure 4—figure supplement 5). The amino acid variant was found in patients from different time
periods and geographical locations (Supplementary file 4), thus it is unlikely that this was a unique
Figure 5. The trimeric and monomeric crystal structures of nucleoprotein (PDB: 3ZDP) (Chenavas et al., 2013) of influenza A viruses. Amino acid sites
with potentially linked epistatic amino acid variants as tabulated in Table 1 are separately colored, with their corresponding positions annotated on the
monomeric structure.
Table 1. FoldX stability predictions of likely linked nonsynonymous minority variants found in A/
H3N2 nucleoprotein.
The mean DDG and standard deviation (SD) values reported are based on the results of five distinct
simulations. Variants with mean DDG<  0:46 kcal/mol are deemed to be stabilizing while destabiliz-
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variant shared among individuals in the same transmission cluster. It was observed as early as day 0
post-symptom onset for some patients and seemed to persist during the infection but only as a
minority variant at varying frequencies (median frequency across all samples with mutation = 0.20;
IQR = 0.08–0.28). However, this position has also been conserved with the wild-type Leucine residue
in the global virus population to date. Hence, it is unclear if HA-L455F/I actually confers any selective
benefit even though it was independently found in multiple patients.
We also found oseltamivir resistance mutation H275Y (Mai et al., 2010) in the NA proteins in two
unlinked individuals who were infected with the A/H1N1pdm09 virus and treated with oseltamivir
(Figure 4—figure supplement 6 and Supplementary file 4). 275Y quickly became the majority vari-
ant in both patients within 3–4 days after the antiviral drug was first administered. Finally, there were
two other amino acid variants in the M2 ion channel that appeared within multiple subjects in paral-
lel across different geographical locations – L46P and F48S were identified in 8 and 16 patients,
respectively, in a range of frequencies (L46P: median frequency = 0.04, IQR = 0.04–0.05; F48S:
median frequency = 0.08, IQR = 0.03–0.13) but similarly, never becoming a majority variant in any of
them (Figure 4 and Figure 4—figure supplement 7). Again, the wild-type residues were mostly
conserved in the global virus population since the pandemic.
Within-host simulations
To investigate the evolutionary pressures that likely underpin the observed within-host dynamics of
A/H3N2 viruses in young children (Figure 2), we performed forward-time Monte Carlo simulations.
Given that the median age of the children infected by A/H3N2 virus at the time of sample collection
was 2 years of age (IQR = 2–3 years), most of them were likely experiencing one of their first influ-
enza virus infections. Furthermore, influenza vaccination for children is not part of the national vacci-
nation program in Vietnam. As such, most of the children analyzed here lacked influenza virus-
specific antibodies based on hemagglutination inhibition assays (Koel et al., 2020). Since seasonal
A/H3N2 viruses have circulated within the human population since 1968, the virus is well adapted to
human hosts at this point such that most nonsynonymous mutations are likely highly deleterious and
would not reach detectable frequencies. We hypothesized that detected variants are mostly
expected to be weakly deleterious, and thus not purged fast enough by selection such that muta-
tion-selection balance was observed.
Our simulations used a simple within-host evolution model represented by a binary genome that
distinguishes between synonymous and nonsynonymous loci. Given that the estimated transmission
bottleneck sizes for seasonal A/H3N2 viruses (McCrone et al., 2018; Ghafari et al., 2020) are nar-
row at 1–2 genomes, we modeled an expanding virus population size during the initial timepoints of
the infection that started with one virion. If within-host virus populations were to evolve neutrally, we
would observe similar synonymous and nonsynonymous evolutionary rates throughout the infection
(Figure 6A). On the other hand, if negative selection is sufficiently strong, accumulation of deleteri-
ous nonsynonymous variants will decrease substantially with time (Figure 6B). Clearly, these patterns
were not observed for A/H3N2 viruses (Figure 2A). However, if most de novo nonsynonymous muta-
tions are only weakly deleterious, we would observe larger synonymous evolutionary rates initially
before nonsynonymous variants accumulate to similar levels (Figure 6C). By then, virion population
size (N) would also be large enough relative to the virus mutation rate (m) (i.e., N  1; Appendix
A5) such that mutation-selection balance is expected and evolutionary rates remain fairly constant,
similar to the patterns empirically observed for within-host A/H3N2 virus populations (Figure 2A).
Discussion
Multiple next-generation sequencing studies have found little evidence of positive selection in sea-
sonal influenza virus populations of acutely infected individuals (McCrone et al., 2018; Dinis et al.,
2016; Debbink et al., 2017; Valesano et al., 2020; Sobel Leonard et al., 2016; McCrone et al.,
2020). Recent modeling work showed that the time required to initiate new antibody production
and asynchrony with virus exponential growth limits the selection of de novo antigenic variants within
host in acute seasonal influenza virus infections (Morris et al., 2020). In contrast, phenotypically rele-
vant variants that were positively selected in within-host virus populations of severely immunocom-
promised patients coincided with those selected by the global seasonal IAV population (Xue et al.,
2017; Lumby et al., 2020). This implies that within-host evolutionary dynamics of seasonal IAVs in
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immunocompromised individuals are likely to be substantially different owing to the increased time
for virus diversity to accumulate and for selection to act (Petrova and Russell, 2018). In other words,
the duration of infection is likely to be critical for positive evolutionary selection to be effective within
host.
Viral shedding duration is often longer in young children infected with seasonal influenza virus
compared to otherwise healthy adults (Ng et al., 2016). Children also play a critical role in ‘driving’
influenza epidemics due to their higher contact and transmission rates (Worby et al., 2015;
Viboud et al., 2004). As such, our seasonal A/H3N2 virus results fill an important gap in the current
literature of within-host evolutionary studies of seasonal IAVs as most of the samples analyzed were
collected from children under the age of 6 years up to 2 weeks post-symptom onset. Importantly,
the absence of antibody-mediated immunity in young unvaccinated children, which would otherwise
reduce the extended duration of infection, has the potential to facilitate other routes of virus
evolution.
Similar to the aforementioned within-host studies, the A/H3N2 virus population within these chil-
dren was characterized by low genetic diversity and dominated by purifying selection early in the
infection. Due to a lack of antibody response against the antigenic regions of HA (Koel et al., 2020),
it is unsurprising that we observed a lack of adaptive changes to the HA antigenic regions, similar to
adults in previous studies (McCrone et al., 2018). We also found that the polymerase genes were
subjected to purifying selection, indicating their critical role in virus replication as negative selection
purges deleterious variation. However, while purifying selection is detectable, it is incomplete
(Xue and Bloom, 2020). We observed that most nonsynonymous variants began to accumulate
around 3–4 days post-symptom onset, with incrementally higher empirical rates as the infection
progressed.
Through simulations of a within-host evolution model, we investigated the hypothesis that in the
absence of any positive selection, the accumulation of nonsynonymous iSNVs was a result of their
neutral or only weakly deleterious effects and the expanding within-host virion population size dur-
ing later timepoints in longer infections of naı̈ve young children such that mutation-selection balance
was reached. In contrast, this balance was not detected in otherwise healthy older children or adults
with short-lived influenza virus infections lasting no more than a week where de novo nonsynony-
mous iSNVs are rarely found (McCrone et al., 2018; Dinis et al., 2016; Debbink et al., 2017;
Valesano et al., 2020; Sobel Leonard et al., 2016; McCrone et al., 2020). The maintenance of
genetic diversity through mutation-selection balance within these young children may provide
Figure 6. Evolutionary rates computed from forward-time Monte Carlo within-host simulations for different mean deleterious effects ( sd ) of
nonsynonymous mutations. We assumed that synonymous mutations are neutral for all simulations. (A) Neutral expectation where all nonsynonymous
mutations are neutral (fneu;NS ¼ 100%). We tested our hypotheses where the majority of nonsynonymous mutations are non-neutral (fneu;NS ¼ 1%) and they
are either (B) strongly ( sd ¼  0:1) or (C) weakly ( sd ¼  0:01) deleterious.
The online version of this article includes the following figure supplement(s) for figure 6:
Figure supplement 1. Number of virions (N) against replicative generation (t) based on a target cell-limited within-host model.
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opportunities for the emergence of phenotypically relevant mutations, which deleterious effects
could be alleviated by the accumulation of a secondary compensatory mutations. For example, in
one individual NP-G384R was accompanied by NP-M426I, which is an anchor residue of a CTL epi-
tope of NP, abrogating recognition by HLA-B*3501-positive CTLs (Berkhoff et al., 2005) but is likely
to be deleterious based on our computational protein stability predictions. G384R, which is located
in a CTL epitope distinct from M426I (Berkhoff et al., 2005), was previously shown to be a stabiliz-
ing substitution (Ashenberg et al., 2013).
Interestingly, we also observed G384R in the minority virus population of 15 other unlinked indi-
viduals. Besides improving NP stability, G384R restores recognition by HLA-B*2705-positive NP-spe-
cific CTLs (Berkhoff et al., 2004). The NP gene segment in the global A/H3N2 virus population has
an evolutionary history of fixating destabilizing amino acid mutations that promote CTL immune
escape alongside stabilizing substitutions that compensate for the deleterious effects of the former
(Gong et al., 2013). The reversal R384G mutation confers CTL escape but is known to be highly del-
eterious. This substitution was fixed in the global A/H3N2 virus population during the early 1990s as
other substitutions such as S259L and E375G epistatically alleviated its destabilizing effects
(Gong et al., 2013). One possible explanation for the emergence of G384R as a minority variant
within these unlinked individuals is that they are all HLA-B*2705 negative. However, we did not col-
lect the necessary blood samples to investigate this possibility.
In contrast, we found a substantially higher fraction of nonsynonymous variants in the within-host
virus populations of individuals infected with A/H1N1pdm09 virus during the pandemic. Owing to
the low number of A/H1N1pdm09 virus samples and different next-generation sequencing platforms
used to sequence samples of the two virus subtypes and consequently differences in base calling
error rates and depth of coverage (Figure 1—figure supplement 1), we were unable to directly
compare the observed levels of within-host genetic diversity and its temporal trends between the
two influenza subtypes here. However, given that only iSNVs with frequencies  2% were called,
low-frequency minority variants arising from technical-related errors should be minimized
(Watson et al., 2013). Importantly, the relative number of nonsynonymous iSNVs identified was far
greater than synonymous ones in the pandemic A/H1N1pdm09 virus infections, suggesting that
there was room for further human host adaptation, particularly in the HA but also in the polymerase
gene segments similar to those observed in other zoonotic influenza virus infections (Welkers et al.,
2019).
Given the tight estimated transmission bottleneck size (Appendix A4), the relatively large number
of iSNVs identified at the start of symptom onset and simulations of within-host evolution
(Figures 1B, 2B, and 6D), it is unlikely that the initial within-host A/H1N1pdm09 virus populations
sampled were the inoculating population that founded the infection. Instead, the inoculating viral
population had already undergone substantial within-host replication during the incubation period
before symptom onset. In fact, four of the individuals analyzed were asymptomatic (i.e., H058/S02,
H089/S04, H186/S05, and H296/S04; Supplementary file 4). Additionally, pre-symptomatic virus
shedding was observed in some of the secondary household cases (Thai et al., 2014) and pre-symp-
tomatic transmission has been documented in other settings (Suess et al., 2012). Nonetheless, this
would not meaningfully impact our conclusions as most of the within-host viral populations sampled
at the start of symptom onset should still constitute those found early in infection and the contrast-
ing feature where nonsynonymous iSNVs outnumbered synonymous ones were not observed in the
seasonal A/H3N2 virus samples.
For both A/H3N2 and A/H1N1pdm09 virus samples, nonsense iSNVs resulting in premature stop
codons were found to accumulate within host, even though only at low proportions. The accumula-
tion of premature stop codon mutations further suggests that while purifying selection dominates
within-host influenza virus populations, it may not be acting strongly enough to completely purge
these lethal nonsense mutations (Xue and Bloom, 2020). Additionally, it has been recently found
that incomplete influenza virus genomes frequently occur at the cellular level and that efficient infec-
tion depends on the complementation between different incomplete genomes (Jacobs et al.,
2019). As such, nonsense mutations may not be as uncommon as previously thought. In particular,
nonsense mutations in position 77 of the M2 ion channel were independently found in 27 unlinked
individuals infected by A/H3N2 virus. While these nonsense mutations are generally considered to
be lethal, ion channel activity is retained even if the M2 protein was prematurely truncated up to
position 70 at its cytoplasmic tail (McCown and Pekosz, 2005).
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Our study has several limitations. The number of iSNVs identified can potentially be biased by
variations in sequencing coverage (Zhao and Illingworth, 2019). As such, the number of iSNVs
observed in one intra-host virus populations may not be directly comparable to another with a dis-
tinct coverage profile (Figure 1—figure supplement 1). As an alternative, the nucleotide diversity p
statistic (Nei and Li, 1979) may be a more robust measure of within-host diversity as it solely
depends on the underlying variant frequencies (Zhao and Illingworth, 2019). Computing the corre-
sponding p statistics for our data, we observed trends in genetic diversity that were similar to those
inferred using iSNV counts (Appendix A2 and Appendix 1—figure 1).
To ensure accurate measurements of virus diversity in intra-host populations, we would also need
to be certain that the estimated variant frequencies precisely reflect the distributions of variants that
comprise the sampled virus populations. The inferred variant frequencies can be significantly dis-
torted if virus load is low (Illingworth et al., 2017; Xue et al., 2018). As such, we limited our analy-
ses for both virus subtypes to samples with Ct values 35, which likely afford sufficient virus material
for sequencing (Xue et al., 2018). We were unable to estimate the amount of frequency estimation
errors for the A/H1N1pdm09 virus samples as only one sequencing replicate was performed using
the universal 8-segment PCR method (Hoffmann et al., 2001). However, for the A/H3N2 virus sam-
ples, independent PCR reactions were performed using three partly overlapping amplicons for all
gene segments other than the nonstructural and matrix genes. We compared the variant frequencies
estimated for any overlapping sites generated by reads derived from distinct amplicons with suffi-
cient coverage (>100). Variant frequencies computed from independent amplicons agreed well
with each other across the range of Ct values of the samples from which variants were identified
(Figure 1—figure supplement 2), affirming the precision of our iSNV frequency estimates for the A/
H3N2 virus samples, including those with higher Ct values.
We also performed additional checks to ensure that our results were not driven by potential PCR
and/or technical artifacts. First, we excluded all iSNVs found under the 75th percentile of frequency
range of A/H3N2 variants that were found in only one of the overlapping amplicons. We then recom-
puted the daily within-host evolutionary rates with the remaining iSNVs (Figure 2—figure supple-
ment 3) and found that the relative temporal trends in synonymous and nonsynonymous rates
remain similar to those in Figure 2A. We also checked that the distributions of frequencies for iSNVs
found in recurrent mutation sites (i.e., NP-384 and M2-77) that are below variant calling threshold
are comparable to those found in their neighboring sites (±10 nucleotide positions; Figure 4—figure
supplement 8). Furthermore, we remapped the sample reads to their respective consensus sequen-
ces to minimize mapping of technical artifacts. We were still able to detect the recurring NP-G384R
and M2-R77* amino acid mutations in multiple individuals and timepoints at similar frequencies
when mapped to the reference genome (Figure 4—figure supplements 4, 5, and 9). As such, these
recurrent mutations are unlikely to have been resulted from erroneous variant calls of artifacts.
Finally, most study participants received oseltamivir during the course of their infections
(Supplementary file 4). Although we were unable to identify any potential effects of enhanced viral
clearance or any other evolutionary effects due to the treatment, besides oseltamivir resistance-asso-
ciated mutations, it is unlikely that the antiviral treatment had a substantial impact on our results.
First, the median timepoint in which the antiviral was initially administered was 4 days post-symptom
onset (IQR = 3–6 days; Supplementary file 4). Previous studies showed that enhanced viral clear-
ance of IAVs was mostly observed among patients who were treated with oseltamivir within 3 days
of symptom onset (South East Asia Infectious Disease Clinical Research Network, 2013;
Lee et al., 2009; Ling et al., 2010). Of note, late timepoint samples in this study (8 days since
symptom onset) mostly came from individuals who started oseltamivir treatments 4 days post-
symptom onset (Figure 1—figure supplement 5). Second, at least in vitro, there were no differen-
ces in the levels of genetic diversity observed in influenza virus populations after multiple serial pas-
sages whether they were treated with oseltamivir or not (Renzette et al., 2014).
To conclude, we presented how intra-host populations of seasonal and pandemic influenza
viruses are subjected to contrasting evolutionary selection pressures. In particular, we showed that
the evolutionary dynamics and ensuing genetic variation of these within-host virus populations
changes during the course of infection, highlighting the importance for sequential sampling, particu-
larly for longer-than-average infections such as those in the young children studied here.
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Materials and methods
Sample collection and viral sequencing
The A/H3N2 virus samples were collected from 52 patients between August 2007 and September
2009 as part of an oseltamivir dosage trial conducted by the South East Asia Infectious Disease Clini-
cal Research Network (SEAICRN), which is detailed in a previous work (South East Asia Infectious
Disease Clinical Research Network, 2013). Briefly, patients with laboratory-confirmed influenza
virus infection and duration of symptoms 10 days were swabbed for nose and throat samples daily
between 0 and 10 days as well as day 14 upon enrolment for the study (Supplementary file 4). All
PCR-confirmed A/H3N2 virus samples with cycle threshold (Ct) values 35 were included for
sequencing.
Library preparation and viral sequencing protocols performed on these A/H3N2 virus samples are
elaborated in detail in Koel et al., 2020. Here, we highlight the key aspects of our preparation and
sequencing procedures. Using segment-specific primers (Supplementary file 3), we performed six
independent PCR reactions, resulting in three partly overlapping amplicons for each influenza virus
gene segment other than the matrix (M) and nonstructural (NS) genes where a single amplicon was
produced to cover the entirety of the relatively shorter M and NS genes. The use of shorter but over-
lapping amplicons in the longer gene segments improves amplification efficiency, ensuring that
these longer segments are sufficiently covered should there be any RNA degradation in the clinical
specimen. These overlapping PCR products were pooled in equimolar concentrations for each sam-
ple and purified for subsequent library preparation. Sequencing libraries were prepared using the
Nextera XT DNA Library Preparation kit (Illumina, FC-131-1096) as described in Koel et al., 2020.
Library pools were sequenced using the Illumina MiSeq 600-cycle MiSeq Reagent Kit v3 (Illumina,
MS-102-3003).
The A/H1N1pdm09 virus samples were obtained as part of a household-based influenza virus
cohort study that was also performed by SEAICRN. The study was conducted between July and
December 2009, involving a total of 270 households in Ha Nam province, Vietnam (Horby et al.,
2012). Similarly, combined nose and throat swabs were collected daily for 10–15 days from individu-
als with influenza-like illness (i.e., presenting symptoms of fever >38˚C and cough, or sore throat)
and their household members, including asymptomatic individuals (Supplementary file 4). We also
analyzed additional samples collected from unlinked hospitalized patients who were infected by the
A/H1N1pdm09 virus from two major Vietnamese cities (Hanoi and Ho Chih Minh) during the first
wave of the pandemic (South East Asia Infectious Disease Clinical Research Network, 2013;
Hien et al., 2010). A total of 32 PCR-confirmed A/H1N1pdm09-infected individuals originating from
both households and hospitalized cases were selected for sequencing based on availability and
Ct values 33 (Supplementary file 4).
For the A/H1N1pdm09 virus samples, RNA extraction was performed manually using the High
Pure RNA isolation kit (Roche) with an on-column DNase treatment according to the manufacturer’s
protocol. Total RNA was eluted in a volume of 50 ml. Universal influenza virus full-genome amplifica-
tion was performed using a universal 8-segment PCR method as described previously
(Watson et al., 2013; Zhou et al., 2009; Jonges et al., 2014). In short, two separate RT-PCRs were
performed for each sample, using primers common-uni12R (50-GCCGGAGCTCTGCAGAT ATCAGC
RAAAGCAGG-30), common-uni12G (50-GCCGGAGCTCTG CAGATATCAGCGAAAGCAGG-30), and
common-uni13 (50-CAGGAA ACAGCTATGACAGTAGAAACAAGG-30). The first RT-PCR mixture
contained the primers common-uni12R and common-uni13. The second RT-PCR mixture contained
the primers common-uni12G and common-uni13, which greatly improved the amplification of the
PB2, PB1, and PA segments. Reactions were performed using the One-Step RT-PCR kit High Fidelity
(Invitrogen) in a volume of 50 ml containing 5.0 ml eluted RNA with final concentrations of 1xSuper-
Script III One-Step RT-PCR buffer, 0.2 mM of each primer, and 1.0 ml SuperScript III RT/Platinum Taq
High Fidelity Enzyme Mix (Invitrogen). Thermal cycling conditions were as follows: reverse transcrip-
tion at 42˚C for 15 min, 55˚C for 15 min, and 60˚C for 5 min; initial denaturation/enzyme activation of
94˚C for 2 min; 5 cycles of 94˚C for 30 s, 45˚C for 30 s, slow ramp (0.5 ˚C/s) to 68˚C, and 68˚C for 3
min; 30 cycles of 94˚C for 30 s, 57˚C for 30 s, and 68˚C for 3 min; and a final extension of 68˚C for 5
min. After the PCR, equal volumes of the two reaction mixtures were combined to produce a well-
distributed mixture of all eight influenza virus segments. All RT-PCRs were performed in duplicate.
Samples were diluted to a DNA concentration of 50 ng/ml followed by ligation of 454 sequencing
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adaptors and molecular identifier (MID) tags using the SPRIworks Fragment Library System II for
Roche GS FLX+ DNA Sequencer (Beckman Coulter), excluding fragments smaller than 350 base
pairs, according to the manufacturer’s protocol to allow for multiplex sequencing per region. The
quantity of properly ligated fragments was determined based on the incorporation efficiency of the
fluorescent primers using FLUOstar OPTIMA (BMG Labtech). Emulsion PCR, bead recovery and
enrichment were performed manually according to the manufacturer’s protocol (Roche), and sam-
ples were sequenced in Roche FLX+ 454. Sequencing was performed at the Sanger Institute, Hinx-
ton, Cambridge, England, as part of the FP7 program EMPERIE. Standard flowgram format (sff) files
containing the filter passed reads were demultiplexed based on the molecular identifier (MID)
sequences using QUASR package version 7.0 (Watson et al., 2013).
Read mapping
Trimmomatic (v0.39; Bolger et al., 2014) was used to discard reads with length <30 bases while
trimming the ends of reads where base quality scores fall below 20. The MAXINFO option was used
to perform adaptive quality trimming, balancing the trade-off between longer read length and toler-
ance of base calling errors (target length = 40, strictness = 0.4). For the A/H3N2 virus samples, the
trimmed paired reads were merged using FLASH (v1.2.11) (Magoč and Salzberg, 2011). All remain-
ing reads were then locally aligned to A/Brisbane/10/2007 genome (GISAID accession: EPI_-
ISL_103644) for A/H3N2 virus samples and A/California/4/2009 genome (EPI_ISL_376192) for A/
H1N1pdm09 virus samples using Bowtie2 (v2.3.5.1) (Langmead and Salzberg, 2012). Aligned reads
with mapping scores falling below 20 alongside bases with quality score (Q-score) below 20 were
discarded.
Variant calling and quality filters
Minority variants of each nucleotide site with a frequency of at least 2% were called if the nucleotide
position was covered at least 50 (H1N1pdm09) or 100 (H3N2) and the probability that the variant













10 , N is the coverage of the nucleotide site in question, and n is the absolute
count of the variant base tallied.
While lower coverage at both ends of individual gene segments was expected, there were also
variable coverage results across gene segments for some samples that were mapped to A/H3N2
virus (Figure 1—figure supplement 1). In order to retain as many samples deemed to have ade-
quate coverage across whole genome, a list of polymorphic nucleotide sites found to have >2%
minority variants in more than one sample was compiled. Each gene segment of a sample was deter-
mined to achieve satisfactory coverage if >70% of these polymorphic sites were covered at least
100. For A/H1N1pdm09, the gene segment of a sample was deemed to be adequately covered if
80% of the gene was covered at least 50.
The number of iSNVs observed in A/H3N2 virus samples collected from subject 1673 (39–94
iSNVs in three samples collected from 3 [D3] to 5 [D5] days post-symptom onset) and the D8 sample
for subject 1878 (73 iSNVs) were substantially greater than the numbers in all other samples. The
putative majority and minority segment-concatenated sequences of these samples did not cluster as
a monophyletic clade among themselves phylogenetically (Figure 1—figure supplement 3), sug-
gesting that these samples might be the product of mixed infections or cross-contamination. These
samples were consequently excluded from further analyses.
Empirical within-host evolutionary rate
The empirical within-host evolutionary rate (rg;t) of each gene segment (g) in a sample collected on t
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where fg;t;i is the frequency of minority variants present in nucleotide site i for gene segment g
and ng;t is the number of all available sites (Xue and Bloom, 2020). Distinct rates were calculated for
synonymous and nonsynonymous iSNVs. If a variant was found in overlapping reading frames and a
nonsynonymous change was observed in any of those frames, it would be accounted for as a nonsy-
nonymous mutation. The corresponding whole-genome evolutionary rate (rt) on day t is computed






The most parsimonious viral haplotypes of each gene segment were reconstructed by fitting the
observed nucleotide variant count data to a Dirichlet multinomial model using a previously devel-
oped ML approach to infer haplotype frequencies (Ghafari et al., 2020). Assuming that the viral
population is made up of a set of K haplotypes with frequencies qk, the observed partial haplotype
frequencies ql for a polymorphic site l can be computed by multiplying a projection matrix Tl. For
instance, if the set of hypothetical full haplotypes is assumed to be {AA, GA, AG}, the observed par-
tial haplotype frequencies for site l ¼ 1, qA  and qG  are computed as
















A list of potential full haplotypes was generated from all combinations of nucleotide variants
observed in all polymorphic sites of the gene segment. Starting from K ¼ 1 full haplotype, the opti-





where L is Dirichlet multinomial likelihood, xl is the observed variant count data for read type l,
and ’ is the overdispersion parameter, assumed to be 1 10 3. Simulated annealing was used to
optimize the haplotype frequencies by running two independent searches for at least 5000 states
(iterations) until convergence was reached. In each state, the distribution of qk was drawn from a
Gaussian distribution centered at the frequency distribution of the previous state with a standard
deviation of 0.05. One additional haplotype was added to the set of K full haplotypes during each
round of optimization.
The resulting K haplotypes reconstructed depend on the order in which the list of potential full
haplotypes is considered. As mentioned above, paired-end reads were merged to produce longer
reads (up to ~500–600 base pairs) for mapping in the case of the seasonal A/H3N2 virus samples.
Additionally, the single-stranded A/H1N1pdm09 viral reads generated from 454 sequencing can be
as long as ~500 base pairs. Consequently, there was a non-trivial number of reads where co-muta-
tions were observed in multiple polymorphic sites. Since iSNV frequencies are generally low, haplo-
types with co-mutating sites would inevitably be relegated to the end of the list order if ranked by
their expected joint probabilities. As such, the list of full potential haplotypes was ordered in
descending order based on the score of each full haplotype set k (sk):
sk ¼ fss;k  fms;k
where fss;k and fms;k are both joint probabilities of the full haplotype k computed in different ways.
fss;k is the expected joint probability frequency calculated from the observed independent frequen-
cies of each variant for each polymorphic site found in the full haplotype k. fms;k is based on the
observed frequencies of variants spanning across the sets of highest hierarchal combination of poly-
morphic sites (fms;k).
For example, given a segment where iSNVs were found in three sites, the following reads were
mapped: (A, A, C), (T, A, C), (A, T, C), (A, C, –), (–, A, C), and (–, T, C). We can immediately see that
the top hierarchal combination of polymorphic sites (i.e., possible haplotypes) are (A, A, C), (T, A,
C), and (A, T, C) (i.e., we would compute fms; A;A;Cð Þ, fms; T ;A;Cð Þ, and fms; A;T ;Cð Þ, respectively). The observed
number of reads with (–, A, C) will be counted towards the computation of both fms; A;A;Cð Þ and
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fms; T ;A;Cð Þ since they could be attributed to either haplotype. Similarly, reads with (–, T, C) will be
absorbed towards the counts to compute fms; A;T;Cð Þ. Finally, we see that reads with (A, C, –) are not a
subset of any of the top hierarchal haplotypes considered. As such, they form the fourth possible
top hierarchal haplotype on its own. As such, if we were to compute the ranking for haplotype (A, A,
C):
s A;A;Cð Þ ¼ fss; A;A;Cð Þ fms; A;A;Cð Þ
¼ f A; ; ð Þ f  ;A; ð Þ f  ; ;Cð Þ
 	
 fms; A;A;Cð Þ
If any nucleotide variants in the observed partial haplotypes were unaccounted for in the current
round of full haplotypes considered, they were assumed to be generated from a cloud of ’noise’
haplotypes that were present in no more than 1%. Bayesian information criterion (BIC) was com-
puted for each set of full haplotypes considered, and the most parsimonious set of K haplotypes
was determined by the lowest BIC value.
Linkage disequilibrium
Using the estimated frequencies of the most parsimonious reconstructed haplotypes, conventional
Lewontin’s metrics of linkage disequilibrium were computed to detect for potential epistatic pairs of
nonsynonymous variants:
LDij ¼ q̂ij  q̂iq̂j
where q̂i and q̂j are the estimated site-independent iSNV frequencies of sites i and j, respectively,
while q̂ij is the frequency estimate of variants encoding co-variants in both i and j. Dividing LD by its







max  q̂iq̂j;  1  q̂ið Þ 1  q̂j
   	
ifLD>0
min q̂i 1  q̂j
  





FoldX (https://foldxsuite.crg.eu/) was used to estimate structural stability effects of likely linked non-
synonymous minority variants found in the NP of within-host A/H3N2 virus populations. At the time
of writing of this paper, there was no A/H3N2-NP structure available. Although the eventual NP
structure (PDB: 3ZDP) adopted for stability analyses was originally derived from H1N1 virus (A/WSN/
33) (Chenavas et al., 2013), it was the most well-resolved (2.69 Å) crystal structure available, with
78.5% amino acid identity relative to the NP of A/Brisbane/10/2007. Previous work has shown that
the mutational effects predicted by FoldX using an NP structure belonging to A/WSN/33 (H1N1)
were similar to those experimentally determined on a A/Brisbane/10/2007 NP (Ashenberg et al.,
2013). FoldX first removed any potential steric clashes to repair the NP structure. It then estimated
differences in free energy changes as a result of the input amino acid mutation (i.e.,
DDG ¼ DGmutant   DGwild type) under default settings (298 K, 0.05 M ionic strength, and pH 7.0). Five
distinct simulations were made to estimate the mean and standard deviation DDG values.
Within-host simulations
We implemented forward-time Monte Carlo simulations with varying population size using a simpli-
fied within-host evolution model to test if our hypotheses could explain the different evolutionary
dynamics observed between A/H3N2 and A/H1N1 viral populations. We assumed that a single virion
leads to a productive influenza virus infection within an individual and computed changes in the virus
population size (N) using a target cell-limited model. New virions are produced upon infection by
existing virions at a rate of bCN, where C is the existing number of target cells while b is the rate of
per-cell per-virion infectious contact. Upon infection, a cell will produce r number of virions before it
is rendered unproductive. We assume that infected individuals did not mount any antibody-medi-
ated immune response, setting the virus’ natural per capita decay rate (d) such that virions continue
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to be present within host for 14 days (Figure 6—figure supplement 1 and Table 2). b is then com-




where C0 is the initial (maximum) target cell population size. We solve the following system of
ordinary differential equations numerically to compute the number of virions per viral replicative







We assume a binary genome of length L, distinguishing between synonymous and nonsynony-
mous loci. For A/H3N2 viruses, we hypothesized that most de novo mutations are either weakly del-
eterious or neutral. To estimate the number of such sites, we aligned A/H3N2 virus sequences that
were collected between 2007 and 2012 and identified all polymorphic sites with variants that did not
fixate over time (i.e., <95% frequency over 1-month intervals). We estimated L¼ 1050 with 838 and
212 synonymous and nonsynonymous loci, respectively.
We tracked the frequency distribution of genotypes present for every generation t. We assumed
that mutations occur at per-locus, per-generation rate m. During each generation t, the number of
virions incurring a single-locus mutation followed a Poisson distribution with mean N tð ÞL. For each
virion, the mutant locus was randomly selected across all loci. We assumed that all synonymous and
a fraction of nonsynonymous sites (fneu;NS) are neutral (i.e., (log) fitness effect s ¼ 0). The remaining
nonsynonymous sites either had an additive deleterious (sd) or beneficial (sb) fitness effect when
mutated. The magnitude of sd / sb follow an exponential distribution with mean effect sj j. Epistasis
was neglected throughout. The distribution of genotypes in the next generation t þ 1 was achieved
by resampling individuals according to Poisson distribution with mean N t þ 1ð ÞPf g; tð Þ, where Pf g; tð Þ
is the relative fitness distribution of genotype g during generation t.
To decrease the computational costs of the simulations, specifically when N tð Þ reaches orders of
10
10   1011 virions (Figure 6—figure supplement 1), we implemented an upper population size limit
of 107 virions. Given the mutation rate assumed (Table 2), N tð Þ  1 for N tð Þ  107 virions, mutation-
selection balance is theoretically expected for a single-locus (deleterious) mutant model (Appendix
A5). We ran 500 simulations for each variable set of fneu;NS and sd / sb values. All parameter values
used in the model are given in Table 2.
Phylogenetic inference
All ML phylogenetic trees were reconstructed with IQTREE (v. 1.6.10) (Nguyen et al., 2015) using
the GTR+I+G4 nucleotide substitution model.
Table 2. Parameter values used in the within-host model.
Parameter Meaning Value (units) Source
- Number of hours per replicative generation 6 hr Assumption
r Average number of virions produced by an infected cell 100 virions Frensing et al., 2016
C0 Initial target cell population size 4  10
8 virions Hadjichrysanthou et al., 2016
d Per capita decay rate Two per-generation Assumption
R0 Within-host basic reproduction number 5 Hadjichrysanthou et al., 2016
m Per-site, per-generation mutation rate 3  10 5 per-site, per-generation McCrone et al., 2020
Han, Felix Garza, Welkers, et al. eLife 2021;10:e68917. DOI: https://doi.org/10.7554/eLife.68917 18 of 29
Research article Evolutionary Biology Microbiology and Infectious Disease
Data availability
All raw sequence data have been deposited at NCBI sequence read archive under BioProject Acces-
sion number PRJNA722099. All custom Python code and Jupyter notebooks to reproduce the analy-
ses in this paper are available online: https://github.com/AMC-LAEB/Within_Host_H3vH1 (copy
archived at swh:1:rev:44e44ddbfab4d157a3c5efd559972f51dec6454a), Han, 2021.
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Appendix 1
A1: hemagglutinin and neuraminidase minority variants in A/H3N2 virus
samples
The amino acid variants emerging in the HA and NA proteins of A/H3N2 virus samples were dis-
cussed in a previous work (Koel et al., 2020). Briefly, given the lack of antibody-mediated immune
response in this cohort of mostly naı̈ve children, HA amino acid variants emerging in putative anti-
genic sites were generally low in frequencies (median frequency = 0.04, IQR = 0.03–0.06) and all
only became detectable 3–4 days post-symptom onset (Figure 4—figure supplement 1). Notably,
two of these intra-host mutations were also found in the global A/H3N2 virus population in high fre-
quencies: HA-S45N and -D53N (H3 numbering without signal peptide). Both mutations are part of
the canonical antigenic site C of H3 and emerged within separate individuals, with D53N eventually
becoming the majority variant (97%) as late as day 13 post-symptom onset in one of them. Oseltami-
vir-resistant amino acid mutations E119V, R292K, and N329K arose in 10 patients that were treated
with the antiviral drug and mostly rose in within-host frequencies only 4–7 days after administration
of oseltamivir (Figure 4—figure supplement 2).
A2: genetic diversity by p statistic
Given that the number of identified iSNVs can potentially be biased by variations in sequencing cov-
erage, genetic diversity was also assessed using nucleotide diversity p statistic (Nei and Li, 1979).
This approach constitutes a more robust measure of within-host diversity as it is solely dependent on
the underlying variant frequencies. While the number of polymorphic sites provides an estimate of
’richness’ in the viral population, it may be incompatible to compare iSNV counts between samples
with different read coverage profiles (Zhao and Illingworth, 2019). In contrast, p is a more robust
metric that is unbiased by sequencing depth. For each site l:
pl ¼
Nl Nl   1ð Þ 
P
j nj;l nj;l   1
  
Nl Nl   1ð Þ
where Nl and nj;l are the coverage and number of reads encoding allele j in site l, respectively







Here, we observed similar trends in genetic diversity when using p statistics compared to iSNVs
counts (Appendix 1—figure 1). p weakly increased with respect to time and Ct values for A/H3N2
viruses (days since illness onset: Spearman ¼ 0:388, p¼ 1:52 10 8; CT: ¼ 0:455, p¼ 3:66 10 10)
while remaining relatively invariant for A/H1N1pdm09 viruses (days since symptom onset: ¼ 0:017,
p¼ 0:92; CT: ¼ 0:240, p¼ 0:13).
A B
Appendix 1—figure 1. Genetic diversity of within-host influenza A virus populations as estimated by
Appendix 1—figure 1 continued on next page
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Appendix 1—figure 1 continued
nucleotide diversity p statistic. Box plots summarizing the p statistic (intra-host single-nucleotide
variants [iSNVs]; median, interquartile range [IQR], and whiskers extending within median 1.5
 IQR) computed for samples with adequate breadth of coverage across the whole influenza
genome. (A) Seasonal A/H3N2 and (B) pandemic A/H1N1pdm09 viruses. All box plots are either
stratified by day(s) since symptom onset or qPCR cycle threshold (Ct) values.
A3: potential linked minority variants in within-host virus populations
For both within-host seasonal A/H3N2 and pandemic A/H1N1 virus populations, there were few
instances of potentially linked nonsynonymous variants, and if such co-variants were to exist, they
were mainly found in the internal gene segments (Supplementary file 2). There was only one pair of
HA amino acid mutations (E261G/L455F) that was encoded by a minority haplotype of A/
H1N1pdm09 viruses infecting one individual, but the normalized Lewontin’s linkage disequilibrium
measure (LD0) was less than 0.5, suggesting a low likelihood that the mutation pair was linked non-
randomly. These potentially linked variants tend to emerge late in the infection (6–7 days post-illness
onset) for both viral subtypes, in inferred haplotypes appearing at low frequencies within-host
(median frequency = 0.08, IQR = 0.03–0.12) that were not shared between multiple individuals.
A4: transmission bottleneck size estimation of pandemic A/
H1N1pdm09 viral infections
Index cases were previously identified for six of the seven households where the pandemic A/
H1N1pdm09 viral samples were collected (Thai et al., 2014). Assuming that the non-index cases
within the same household were secondarily infected by the index case, five transmission pairs were
identified where samples with adequate breadth of coverage (>70% of genome covered with >50
coverage; Appendix 1—figure 2) were collected from the index patient on an earlier date relative
to the secondary case.
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Appendix 1—figure 2. A/H1N1pdm09 virus household transmission pairs. (A) Schematic of A/
H1N1pdm09 virus household transmission pairs identified by epidemiological linkage and plotted
based on timing of sample collection (left panel) Intra-host single-nucleotide variant (iSNV)
frequencies found in the donors and recipients of the five transmission pairs (right panel). (B) Violin
plots of L1-norm pairwise genetic distance per site between different A/H1N1pdm09 virus sample
pairs (each circle = 1 pair of virus samples). Transmission pairs are those represented in Figure 5A.
Longitudinal pairs are made up of sample pairs collected from the same individual on the first and
any other later timepoints on which the patient was sampled. These pairs are stratified by whether
they were collected from households located in the same community (i.e., household) or combined
with the rest of the analyzed A/H1N1pdm09 virus samples collected from hospitals (i.e., all). For the
same aforementioned categories, we also plotted the distribution of L1-norm distances for pairs of
viruses collected from different individuals. All circles are colored by the difference in days between
which the sample pairs were collected (DT ). All p-values reported are based on Mann–Whitney U
tests, which were used to determine if the L1-norm genetic distance distributions of the two
categories marked by the ends of the horizontal line above are statistically distinct.
Virus transmission bottleneck sizes were then estimated using two binomial sampling models that
were elaborated in detail by Sobel Leonard et al., 2017 and McCrone et al., 2018. First, the
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presence/absence model computes transmission probability as the probability that a transmitted
donor iSNV was found in at least one genome in the bottleneck population:
Pd;i AjNbð Þ ¼ p
Nb
d;A
where A refers to the transmitted iSNV in polymorphic site i, Nb is the bottleneck size, and pd;A is
the frequency of allele A in the sampled virus population within donor d.
The presence/absence model does not incorporate recipient frequencies of transmitted iSNVs in
its probability calculations. It assumes that all transmitted iSNVs are detected in the recipient, and
thus any donor iSNVs that are not present in the recipient are considered to have not been transmit-
ted. It also does not account for any changes to pd between the time of sampling and day of trans-
mission. The ML estimate of Nb would thus yield the largest log likelihood value given by






To incorporate information on recipient frequencies that can change between transmission and
sampling, transmission bottleneck sizes were re-estimated using a second beta-binomial model for-
mulated by Sobel Leonard et al., 2017. For each allele A observed in polymorphic site i that was















where pbeta pr;Ai jk;Nb   k
  
is the conditional probability density, as modelled by the beta distribu-
tion, that the transmitted iSNV, Ai, is found in the recipient at frequency pr;Ai given that the variant is
found present in k genomes out of the total transmission bottleneck of Nb genomes. pbin kjNb;pd;Ai
  
is the binomial probability of drawing k genomes with allele Ai in a sample of Nb genomes and vari-
ant frequency of pd;Ai within the donor.
As some of the iSNVs in the donor may not be transmitted or were present below the 2% mini-















where pbeta;cdf is the cumulative distribution function of the beta distribution.
The ML estimate of Nb as described by the beta-binomial was then computed by searching for
the value of Nb that would give the largest value of





d;r þLL Nbð Þ
lost
d;r
Log-likelihood values were computed for a range Nb between 1 and 1000 genomes for both
models.
Transmission bottleneck size was then estimated by aggregating over all transmission pairs and
applying two previously developed sampling-based models (McCrone et al., 2018; Sobel Leonard
et al., 2017). We estimated the transmission bottleneck of pandemic A/H1N1pdm09 viruses to be
1–2 genomes (ML presence-absence model estimate = 1 genome; ML beta-binomial model estimate
= 2 genomes). The tight bottleneck was further reflected in the iSNV frequency plot where most of
the donor variants were either present as the single majority allele or were not transmitted/unde-
tected in the recipient, with few shared iSNVs between the two virus populations (Appendix 1—fig-
ure 2A).
Furthermore, we observed that the virus populations between patients (median L1-norm distance
= 0.031 divergence per site, IQR = 0.024–0.046 divergence per site) were significantly more different
than longitudinal samples collected from the same individual (median L1-norm distance = 2:35
10
 3 divergence per site, IQR = 1:54 10 3   3:18 10 3 divergence per site), suggesting that the
haplotypes found within an individual remain relatively invariant throughout the course of infection
(Appendix 1—figure 2B). Combined with the fact that the per-site L1-norm genetic distance
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between samples attributed to the identified transmission pairs (median L1-norm distance = 6:49
10
 3 divergence per site, IQR = 6:34 10 3   6:63 10 3 divergence per site) was greater than those
computed for longitudinal sample pairs of each household individual (median L1-norm distance =
2:77 10 3 divergence per site, IQR = 2:18 10 3   3:32 10 3 divergence per site; Mann–Whitney
U p-value=0.01; Appendix 1—figure 2B), it is likely that only a limited number of haplotypes were
shared between individuals in a transmission pair. Based on the most parsimonious reconstructed
haplotypes for the five transmission pairs encoding shared iSNVs, we estimated the median number
of haplotypes transmitted from donor to recipient to be between 1 and 2 haplotypes.
A5: mutation-selection balance
Considering a single-locus mutant with deleterious fitness effect s (i.e., s<0), the frequency of the
mutant allele (f ) can be modeled by the following stochastic differential equation, otherwise known
as the Langevin equation (Good and Desai, 2013):
qf
qt
¼ sf 1  fð Þþ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
f   1  fð Þ
N
r
h tð Þþ 1  fð Þ
selection genetic drift mutation
where N is the population size, m is the mutation rate, and h tð Þ is the stochastic noise term due to
genetic drift. For any Langevin equation, we can find the time-dependent probability distribution of
f (i.e., qp f ;tð Þ
qt
) by its corresponding Fokker–Planck equation. At stationarity (i.e., qp f ;tð Þ
qt
¼ 0), its solution
is known to be
p fð Þ /
e 2NL fð Þ
f 1  fð Þ




Integrating   qL fð Þ
qt
, we will get
 L fð Þ ¼ sf þ ln f
which can then be substituted to obtain
p fð Þ / e2Nsf  f 2N 1
In other words, p fð Þ strongly depends on N. If N 1, we can see that p fð Þ will strongly peak at
some characteristic value of f that minimizes L fð Þ. If N is large, we can assume that drift effects are
negligible and f is largely deterministic due to selection:
qf
qt
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